PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cancer Biology and Genetics, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA. Dario.Palmieri@osumc.edu.\', \'Public Health and Preventive Medicine Department, US Air Force School of Aerospace Medicine, Wright-Patterson Air Force Base, OH, 45433, USA.\', \'Department of Cancer Biology and Genetics, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA.\', \'Department of Cancer Biology and Genetics, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA. rfishel@osu.edu.\', \'Department of Cancer Biology and Genetics, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA. wayne.miles@osumc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-08034-1
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35260723
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Mass COVID-19 patient screening using UvsX and UvsY mediated DNA recombination and high throughput parallel sequencing.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all